Deutsche Bank AG Has $15.14 Million Stake in Maximus, Inc. (NYSE:MMS)

Deutsche Bank AG boosted its position in Maximus, Inc. (NYSE:MMS - Free Report) by 8.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 202,834 shares of the health services provider's stock after acquiring an additional 15,539 shares during the quarter. Deutsche Bank AG owned 0.36% of Maximus worth $15,142,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Dean Capital Management raised its holdings in Maximus by 70.9% in the 4th quarter. Dean Capital Management now owns 39,513 shares of the health services provider's stock worth $2,950,000 after purchasing an additional 16,398 shares in the last quarter. EP Wealth Advisors LLC lifted its stake in shares of Maximus by 17.1% in the 4th quarter. EP Wealth Advisors LLC now owns 3,387 shares of the health services provider's stock worth $253,000 after purchasing an additional 495 shares during the period. Captrust Financial Advisors purchased a new stake in shares of Maximus in the 4th quarter worth $276,000. Algert Global LLC lifted its stake in shares of Maximus by 12.1% during the 4th quarter. Algert Global LLC now owns 187,017 shares of the health services provider's stock valued at $13,961,000 after buying an additional 20,215 shares in the last quarter. Finally, Freestone Grove Partners LP bought a new position in shares of Maximus during the fourth quarter worth $1,718,000. Hedge funds and other institutional investors own 97.21% of the company's stock.

Analyst Upgrades and Downgrades

Separately, StockNews.com cut shares of Maximus from a "buy" rating to a "hold" rating in a research report on Thursday.

Insider Buying and Selling at Maximus

In other news, Director Jan Madsen sold 2,439 shares of the business's stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the sale, the director now directly owns 18,097 shares in the company, valued at approximately $1,225,347.87. The trade was a 11.88% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Ilene R. Baylinson sold 14,500 shares of the stock in a transaction dated Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the sale, the insider now owns 2,512 shares in the company, valued at approximately $171,167.68. This trade represents a 85.23% decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by company insiders.

Maximus Stock Performance

Shares of NYSE MMS traded up $0.17 during trading on Monday, reaching $75.16. 342,414 shares of the company traded hands, compared to its average volume of 561,468. The stock has a market cap of $4.24 billion, a P/E ratio of 16.16 and a beta of 0.61. Maximus, Inc. has a 12-month low of $63.77 and a 12-month high of $93.97. The firm's fifty day simple moving average is $68.71 and its 200 day simple moving average is $72.55. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82.

Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.37 by $0.64. Maximus had a net margin of 5.28% and a return on equity of 21.95%. The business had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.29 billion. During the same quarter last year, the firm earned $1.57 EPS. The business's revenue was up 1.0% compared to the same quarter last year. As a group, research analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Saturday, May 31st. Investors of record on Thursday, May 15th will be given a $0.30 dividend. The ex-dividend date is Thursday, May 15th. This represents a $1.20 annualized dividend and a yield of 1.60%. Maximus's dividend payout ratio (DPR) is 23.86%.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.